Immatics N.V. (IMTX) Social Stream



Immatics N.V. (IMTX): $7.01

-0.31 (-4.23%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add IMTX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 384

in industry

IMMATICS NV (IMTX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering IMTX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-18 4 $30 $19 $24.25 $7.38 228.59%
2022-03-23 4 $32 $19 $25.25 $7.38 242.14%
2022-03-24 4 $30 $20 $23.75 $7.38 221.82%
2022-06-02 4 $30 $14 $22.25 $7.38 201.49%
2022-06-07 4 $30 $14 $22.5 $7.38 204.88%
2022-07-14 4 $30 $14 $20.25 $7.38 174.39%
2022-08-10 4 $28 $16 $20.25 $7.38 174.39%
2023-02-08 4 $28.9 $16 $20.475 $7.38 177.44%

The Trend in the Analyst Price Target


Over the past 15 months, IMTX's average price target has gone down $3.77.

IMTX reports an average of 129.92% for its upside potential over the past 46 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-03-23 4 32.0 19 25.250 7.53 235.33%
2022-08-10 4 28.0 16 20.250 11.99 68.89%
2022-09-17 4 28.9 16 20.475 10.36 97.64%
2022-11-21 4 28.9 16 20.475 9.94 105.99%
2023-01-26 4 28.9 16 20.475 7.81 162.16%

IMTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The Trend in the Broker Recommendations


IMTX's average broker recommendation rating improved by 0.2 over the prior 16 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for IMTX as an investment opportunity.

  • IMMATICS NV's number of analysts covering the stock is greater than 124.4% of all US stocks.
  • IMMATICS NV's upside potential (average analyst target price relative to current price) is greater than 666.26% of all US stocks.
  • IMMATICS NV's average analyst price target is greater than 221.79% of all US stocks.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, IMMATICS NV's variance in analysts' estimates is lower than -423.59% of them.

Stocks similar to IMMATICS NV in the Pharmaceutical Products industry regarding analyst recommendations and price targets are GRTS, STRO, and AUTL.

Is IMTX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7668 seconds.